ARIA 2016: Resumen ejecutivo vías de atención integradas para una medicina preventiva a lo largo del ciclo vital

Autores/as

  • María Antonieta Guzmán M. ARIA Chile
  • Mario Calvo Aria Chile
  • Nancy Abusada A. ARIA Chile
  • Alejandro Afani S. ARIA Chile
  • Emilio Álvarez ARIA Chile
  • Jorge Caro ARIA Chile
  • Tamara Pérez ARIA Chile
  • Mauricio Ruiz C. ARIA Chile
  • Cecilia Sepúlveda C. ARIA Chile
  • Felipe Valdés A. ARIA Chile
  • Ioana Agache ARIA Chile
  • Claus Bachert Bachert ARIA Chile
  • Anna Bedrook ARIA Chile
  • G Walter Canonica ARIA Chile
  • Thomas Casale ARIA Chile
  • Alvaro Cruz ARIA Chile
  • Wytske Fokkens ARIA Chile
  • Peter W Hellings ARIA Chile
  • Boleslaw Samolinski
  • Jean Bousquet ARIA Chile

Resumen

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA - disseminated and implemented in over 70 countries globally - is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK (MACVIA (Contre les MAladies Chroniques pour un VIeillissement Actif)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multi-disciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing.

Palabras clave:

Rinitis Alérgica, Asma